Danaher Corp. (DHR)
232.00
-4.98
(-2.10%)
USD |
NYSE |
Oct 30, 12:34
Danaher Cash from Operations (Quarterly) : 1.886B for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.886B |
| June 30, 2026 | 1.534B |
| March 31, 2026 | 1.322B |
| December 31, 2025 | 2.117B |
| September 30, 2025 | 1.662B |
| June 30, 2025 | 1.338B |
| March 31, 2025 | 1.299B |
| December 31, 2024 | 2.019B |
| September 30, 2024 | 1.513B |
| June 30, 2024 | 1.417B |
| March 31, 2024 | 1.739B |
| December 31, 2023 | 1.619B |
| September 30, 2023 | 1.672B |
| June 30, 2023 | 1.926B |
| March 31, 2023 | 1.947B |
| December 31, 2022 | 2.541B |
| September 30, 2022 | 2.01B |
| June 30, 2022 | 2.00B |
| March 31, 2022 | 1.968B |
| December 31, 2021 | 2.333B |
| September 30, 2021 | 2.034B |
| June 30, 2021 | 2.12B |
| March 31, 2021 | 1.871B |
| December 31, 2020 | 2.221B |
| September 30, 2020 | 1.723B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.445B |
| March 31, 2020 | 819.00M |
| December 31, 2019 | 1.111B |
| September 30, 2019 | 965.60M |
| June 30, 2019 | 1.172B |
| March 31, 2019 | 703.30M |
| December 31, 2018 | 1.238B |
| September 30, 2018 | 919.50M |
| June 30, 2018 | 1.036B |
| March 31, 2018 | 828.90M |
| December 31, 2017 | 834.70M |
| September 30, 2017 | 1.072B |
| June 30, 2017 | 1.010B |
| March 31, 2017 | 560.20M |
| December 31, 2016 | 649.00M |
| September 30, 2016 | 818.20M |
| June 30, 2016 | 1.282B |
| March 31, 2016 | 772.80M |
| December 31, 2015 | 1.232B |
| September 30, 2015 | 952.60M |
| June 30, 2015 | 1.094B |
| March 31, 2015 | 523.60M |
| December 31, 2014 | 1.239B |
| September 30, 2014 | 1.016B |
| June 30, 2014 | 991.70M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 2.55B |
| Agilent Technologies, Inc. | 519.00M |
| Bio-Rad Laboratories, Inc. | 98.70M |
| Revvity, Inc. | 191.94M |
| Illumina, Inc. | 201.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -300.00M |
| Cash from Financing (Quarterly) | -262.00M |
| Free Cash Flow | 5.727B |
| Free Cash Flow Per Share (Quarterly) | 2.308 |
| Free Cash Flow to Equity (Quarterly) | 1.707B |
| Free Cash Flow to Firm (Quarterly) | 1.775B |
| Free Cash Flow Yield | 3.48% |